EUVIMEDEUVIMED entdecken
Open Access

Survival prediction in stage II/III rectal cancer: Role of immune‑inflammatory biomarkers post neoadjuvant chemoradiotherapy

Bingjie Li, Taotao Huang, Shijing Xu, Yuhuan Ye, Yong Liu, Xiaoyu Wang, Yongsheng Wang

Oncology Letters · 29.05.2026 · 32 (1) · 1-9

DOI: 10.3892/ol.2026.15672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 29.05.2026. Verfasst von Bingjie Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy, Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Cheng…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

disease-free survivalimmune-inflammatory biomarkersneoadjuvant chemoradiotherapyoverall survivalrectal cancerrisk stratification

Autor:innen und Institutionen

  • State Key Laboratory of Biotherapy, Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.

Zitieren

APA

Li, B., Huang, T., Xu, S., Ye, Y., Liu, Y., Wang, X., & Wang, Y. (2026). Survival prediction in stage II/III rectal cancer: Role of immune‑inflammatory biomarkers post neoadjuvant chemoradiotherapy. Oncology Letters, 32(1), 1-9. https://doi.org/10.3892/ol.2026.15672

Vancouver

Li B, Huang T, Xu S, Ye Y, Liu Y, Wang X, et al. Survival prediction in stage II/III rectal cancer: Role of immune‑inflammatory biomarkers post neoadjuvant chemoradiotherapy. Oncology Letters. 2026;32(1):1-9. doi:10.3892/ol.2026.15672

BibTeX
@article{Li2026,
  author = {Li, Bingjie and Huang, Taotao and Xu, Shijing and Ye, Yuhuan and Liu, Yong and Wang, Xiaoyu and Wang, Yongsheng},
  title = {Survival prediction in stage II/III rectal cancer: Role of immune‑inflammatory biomarkers post neoadjuvant chemoradiotherapy},
  journal = {Oncology Letters},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {1--9},
  doi = {10.3892/ol.2026.15672}
}
Kostenlos starten →